Novel drug molecule offers hope for early Parkinson's disease treatment
A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new ...
Tag: Biogen
Biodegradable diagnostic tests offer sustainable solution to plastic pollution
The global plastic pollution crisis and the fallout from the COVID-19 pandemic – where billions of single-use diagnostic tests were discarded – ...
One copy of the Christchurch variant may confer protection against familial Alzheimer's disease
A scientific story that began with a discovery in just one extraordinary patient is now panning out. In 2019, an ...
Study highlights global fertility decline and its implications for the future
The world is approaching a low-fertility future. Although by 2100 more than 97% of countries and territories will have fertility ...
Football players at increased risk for Parkinson's disease, study finds
Identification of risk factors for Parkinson's disease (PD) is essential for early diagnosis. Dating back to the 1920s, Parkinson's disease ...
Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference
Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa® technology has powered important advances ...
Amyloid-PET scanning has misled the FDA into granting approval for Aduhelm
Last year, the FDA gave accelerated approval of the antibody aducanumab (marketed as Aduhelm by Biogen) for the treatment of ...
Researchers discover two important novel aspects of APOE4 gene in Alzheimer's patients
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million ...
